EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

MiRNAs and Their Role in Venous Thromboembolic Complications

Ilgiz Gareev iD, Valentin Pavlov iD, Weijie Du, Baofeng Yang

Diagnostics · 04.11.2023 · 13 (21) · 3383

DOI: 10.3390/diagnostics13213383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 04.11.2023. Verfasst von Ilgiz Gareev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Central Research Laboratory, Bashkir State Medical University, 3 Lenin Street, 450008 Ufa, Russia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Bashkir State Medical University Strategic Academic Leadership Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venous thromboembolic complications (VTCs), which include deep vein thrombosis (DVT) and pulmonary embolism (PE), have remained a pressing problem in modern clinical medicine for a long time. Despite the already wide arsenal of modern methods for diagnosing and treating this disease, VTCs rank third in the structure of causes of death among all cardiovascular diseases, behind myocardial infarction (MI) and ischemic stroke (IS). Numerous studies have confirmed the importance of understanding the molecular processes of VTCs for effective therapy and diagnosis. Significant progress has been made in VTC research in recent years, where the relative contribution of microRNAs (miRNAs) in the mechanism of thrombus formation and their consideration as therapeutic targets have been well studied. In this case, accurate, timely, and as early as possible diagnosis of VTCs is of particular importance, which will help improve both short-term and long-term prognoses of patients. This case accounts for the already well-studied circulating miRNAs as non-invasive biomarkers. This study presents currently available literature data on the role of miRNAs in VTCs, revealing their potential as therapeutic targets and diagnostic and prognostic tools for this terrible disease.

Schlagwörter

Stichwörter der Autor:innen

biomarkerscardiovascular diseasehemostasismiRNAtherapeutic targetsvenous thromboembolic complications

Autor:innen und Institutionen

  • Central Research Laboratory, Bashkir State Medical University, 3 Lenin Street, 450008 Ufa, Russia.
  • Department of Urology, Bashkir State Medical University, 3 Lenin Street, 450008 Ufa, Russia.
  • Department of Pharmacology, The Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150067, China.
  • Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China.

ORCID-Profile: Ilgiz Gareev, Valentin Pavlov

Förderung

  • National Natural Science Foundation of China
  • Bashkir State Medical University Strategic Academic Leadership Program

Zitieren

APA

Gareev, I., Pavlov, V., Du, W., & Yang, B. (2023). MiRNAs and Their Role in Venous Thromboembolic Complications. Diagnostics, 13(21), 3383. https://doi.org/10.3390/diagnostics13213383

Vancouver

Gareev I, Pavlov V, Du W, Yang B. MiRNAs and Their Role in Venous Thromboembolic Complications. Diagnostics. 2023;13(21):3383. doi:10.3390/diagnostics13213383

BibTeX
@article{Gareev2023,
  author = {Gareev, Ilgiz and Pavlov, Valentin and Du, Weijie and Yang, Baofeng},
  title = {MiRNAs and Their Role in Venous Thromboembolic Complications},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {21},
  pages = {3383},
  doi = {10.3390/diagnostics13213383}
}
Kostenlos starten →